Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (641-650 of 1,708) with videos related to

Pageof 171
Sort By:
Diabetes, Obesity & Metabolism|February 10, 2017
Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome studyAvivit Cahn, Ofri Mosenzon, Deepak L Bhatt, et al.
The American Journal of Cardiology|July 13, 2004
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortalityVivek Rajagopal, Hitinder S Gurm, Deepak L Bhatt, et al.
European Heart Journal|July 19, 2018
Patent foramen ovale and long-term risk of ischaemic stroke after surgerySabine Friedrich, Pauline Y Ng, Katharina Platzbecker, et al.
Diabetes Research and Clinical Practice|May 30, 2017
Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trialAndrew H Briggs, Deepak L Bhatt, Benjamin M Scirica, et al.
Lancet (London, England)|September 4, 2016
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort studyEmmanuelle Vidal-Petiot, Ian Ford, Nicola Greenlaw, et al.
Journal of Cardiac Failure|August 3, 2011
Predictors of hospital length of stay in heart failure: findings from Get With the GuidelinesDavid J Whellan, Xin Zhao, Adrian F Hernandez, et al.
The American Journal of Cardiology|April 5, 2020
Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure RiskMuthiah Vaduganathan, Avinainder Singh, Abhinav Sharma, et al.
Circulation|December 6, 2021
Methodological Standards for the Design, Implementation, and Analysis of Randomized Trials in Cardiac Surgery: A Scientific Statement From the American Heart AssociationMario Gaudino, Joanna Chikwe, Emilia Bagiella, et al.
The New England Journal of Medicine|March 19, 2019
Antibody-Based Ticagrelor Reversal Agent in Healthy VolunteersDeepak L Bhatt, Charles V Pollack, Jeffrey I Weitz, et al.
American Heart Journal|February 7, 2012
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarctionHarvey D White, Derek P Chew, Harold L Dauerman, et al.
Pageof 171

Showing results (641-650 of 1,708) with videos related to

Sort By:
Pageof 171
Diabetes, Obesity & Metabolism|February 10, 2017
Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome studyAvivit Cahn, Ofri Mosenzon, Deepak L Bhatt, et al.
The American Journal of Cardiology|July 13, 2004
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortalityVivek Rajagopal, Hitinder S Gurm, Deepak L Bhatt, et al.
European Heart Journal|July 19, 2018
Patent foramen ovale and long-term risk of ischaemic stroke after surgerySabine Friedrich, Pauline Y Ng, Katharina Platzbecker, et al.
Diabetes Research and Clinical Practice|May 30, 2017
Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trialAndrew H Briggs, Deepak L Bhatt, Benjamin M Scirica, et al.
Lancet (London, England)|September 4, 2016
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort studyEmmanuelle Vidal-Petiot, Ian Ford, Nicola Greenlaw, et al.
Journal of Cardiac Failure|August 3, 2011
Predictors of hospital length of stay in heart failure: findings from Get With the GuidelinesDavid J Whellan, Xin Zhao, Adrian F Hernandez, et al.
The American Journal of Cardiology|April 5, 2020
Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure RiskMuthiah Vaduganathan, Avinainder Singh, Abhinav Sharma, et al.
Circulation|December 6, 2021
Methodological Standards for the Design, Implementation, and Analysis of Randomized Trials in Cardiac Surgery: A Scientific Statement From the American Heart AssociationMario Gaudino, Joanna Chikwe, Emilia Bagiella, et al.
The New England Journal of Medicine|March 19, 2019
Antibody-Based Ticagrelor Reversal Agent in Healthy VolunteersDeepak L Bhatt, Charles V Pollack, Jeffrey I Weitz, et al.
American Heart Journal|February 7, 2012
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarctionHarvey D White, Derek P Chew, Harold L Dauerman, et al.
Pageof 171